† This indicator looks at treatment patterns within one year of diagnosis and within one year post-surgery for adjuvant radiation therapy. ‡ The categories 'Radiation therapy only' and 'Surgery with adjuvant radiation therapy' were combined due to small numbers and/or to avoid residual disclosure.
No record of treatment may include, but is not limited to, surgeries other than radical prostatectomy, active surveillance, watchful waiting, hormone therapy, chemotherapy and patient refusal.
Radiation therapy includes both external beam radiation therapy and brachytherapy. Surgery includes radical prostatectomy.
Data source: Provincial cancer agencies.
Data Table
Province
Type of Primary Treatment
Cases
Percent (%)
Lower bound of 95% confidence interval
Upper bound of 95% confidence interval
BC
No record of treatment
232
26.7
23.8
29.8
BC
Radiation therapy only
393
45.2
41.9
48.6
BC
Surgery with adjuvant radiation therapy
71
8.2
6.4
10.2
BC
Surgery only
173
19.9
17.3
22.7
AB
No record of treatment
227
50.9
46.2
55.6
AB
Radiation therapy only
163
36.5
32.1
41.2
AB
Surgery with adjuvant radiation therapy
19
4.3
2.6
6.6
AB
Surgery only
37
8.3
5.9
11.3
SK
No record of treatment
81
46.6
39.0
54.3
SK
Radiation therapy only
65
37.4
30.2
45.0
SK
Surgery with adjuvant radiation therapy
8
4.6
2.0
8.9
SK
Surgery only
20
11.5
7.2
17.2
MB
No record of treatment
128
56.6
49.9
63.2
MB
Radiation therapy only/ Surgery with adjuvant radiation therapy
49
21.7
16.5
27.6
MB
Surgery only
49
21.7
16.5
27.6
NS
No record of treatment
82
53.6
45.4
61.7
NS
Radiation therapy only
45
29.4
22.3
37.3
NS
Surgery with adjuvant radiation therapy
9
5.9
2.7
10.9
NS
Surgery only
17
11.1
6.6
17.2
PE
No record of treatment
12
44.4
25.5
64.7
PE
Radiation therapy only/ Surgery with adjuvant radiation therapy
† This indicator looks at treatment patterns within one year of diagnosis and within one year post-surgery for adjuvant radiation therapy. ‡ The categories 'Radiation therapy only' and 'Surgery with adjuvant radiation therapy' were combined due to small numbers and/or to avoid residual disclosure.
No record of treatment may include, but is not limited to, surgeries other than radical prostatectomy, active surveillance, watchful waiting, hormone therapy, chemotherapy and patient refusal.
Radiation therapy includes both external beam radiation therapy and brachytherapy. Surgery includes radical prostatectomy.
Data source: Provincial cancer agencies.
Figure 4.21b
Percentage of intermediate-risk prostate cancer patients (men aged ≥ 35) receiving various types of treatment,† by province — 2010 diagnosis year
† This indicator looks at treatment patterns within one year of diagnosis and within one year post-surgery for adjuvant radiation therapy. ‡ The categories 'Radiation therapy only' and 'Surgery with adjuvant radiation therapy' were combined due to small numbers and/or to avoid residual disclosure.
No record of treatment may include, but is not limited to, surgeries other than radical prostatectomy, active surveillance, watchful waiting, hormone therapy, chemotherapy and patient refusal.
Radiation therapy includes both external beam radiation therapy and brachytherapy. Surgery includes radical prostatectomy.
Data source: Provincial cancer agencies.
Data Table
Province
Type of Primary Treatment
Cases
Percent (%)
Lower bound of 95% confidence interval
Upper bound of 95% confidence interval
BC
No record of treatment
156
20.7
17.9
23.8
BC
Radiation therapy only
400
53.2
49.6
56.8
BC
Surgery with adjuvant radiation therapy
21
2.8
1.7
4.2
BC
Surgery only
175
23.3
20.3
26.5
AB
No record of treatment
281
30.2
27.2
33.2
AB
Radiation therapy only
220
23.6
20.9
26.5
AB
Surgery with adjuvant radiation therapy
40
4.3
3.1
5.8
AB
Surgery only
395
42.0
38.8
45.2
SK
No record of treatment
64
30.8
24.6
37.5
SK
Radiation therapy only
89
42.8
36.0
49.8
SK
Surgery with adjuvant radiation therapy
11
5.3
2.7
9.3
SK
Surgery only
44
21.2
15.8
27.3
MB
No record of treatment
119
43.9
37.9
50.0
MB
Radiation therapy only/ Surgery with adjuvant radiation therapy
61
22.5
17.7
28.0
MB
Surgery only
91
33.6
28.0
39.5
NS
No record of treatment
100
40.7
34.5
47.1
NS
Radiation therapy only
55
22.4
17.3
28.1
NS
Surgery with adjuvant radiation therapy
23
9.3
6.0
13.7
NS
Surgery only
68
27.6
22.2
33.7
PE
No record of treatment
12
30.0
16.6
46.5
PE
Radiation therapy only/ Surgery with adjuvant radiation therapy
† This indicator looks at treatment patterns within one year of diagnosis and within one year post-surgery for adjuvant radiation therapy. ‡ The categories 'Radiation therapy only' and 'Surgery with adjuvant radiation therapy' were combined due to small numbers and/or to avoid residual disclosure.
No record of treatment may include, but is not limited to, surgeries other than radical prostatectomy, active surveillance, watchful waiting, hormone therapy, chemotherapy and patient refusal.
Radiation therapy includes both external beam radiation therapy and brachytherapy. Surgery includes radical prostatectomy.
Data source: Provincial cancer agencies.
Figure 4.21c
Percentage of low-risk prostate cancer patients (men aged ≥ 35) receiving various types of treatment,† by province — 2010 diagnosis year
† This indicator looks at treatment patterns within one year of diagnosis and within one year post-surgery for adjuvant radiation therapy. ‡ The categories 'Radiation therapy only' and 'Surgery with adjuvant radiation therapy' were combined due to small numbers and/or to avoid residual disclosure.
No record of treatment may include, but is not limited to, surgeries other than radical prostatectomy, active surveillance, watchful waiting, hormone therapy, chemotherapy and patient refusal.
Radiation therapy includes both external beam radiation therapy and brachytherapy. Surgery includes radical prostatectomy.
Data source: Provincial cancer agencies.
Data Table
Province
Type of Primary Treatment
Cases
Percent (%)
Lower bound of 95% confidence interval
Upper bound of 95% confidence interval
BC
No record of treatment
123
46.7
40.8
52.6
BC
Radiation therapy only
84
29.5
24.2
35.1
BC
Surgery with adjuvant radiation therapy
5
1.8
0.6
4.0
BC
Surgery only
63
22.1
17.4
27.4
AB
No record of treatment
192
41.5
36.9
46.1
AB
Radiation therapy only
98
21.2
17.5
25.2
AB
Surgery with adjuvant radiation therapy
5
1.1
0.4
2.5
AB
Surgery only
168
36.3
31.9
40.8
SK
No record of treatment
27
48.7
39.4
58.1
SK
Radiation therapy only
24
20.5
13.6
29.0
SK
Surgery only
36
30.8
22.6
40.0
MB
No record of treatment
73
73.7
63.9
82.1
MB
Radiation therapy only/ Surgery with adjuvant radiation therapy
† This indicator looks at treatment patterns within one year of diagnosis and within one year post-surgery for adjuvant radiation therapy. ‡ The categories 'Radiation therapy only' and 'Surgery with adjuvant radiation therapy' were combined due to small numbers and/or to avoid residual disclosure.
No record of treatment may include, but is not limited to, surgeries other than radical prostatectomy, active surveillance, watchful waiting, hormone therapy, chemotherapy and patient refusal.
Radiation therapy includes both external beam radiation therapy and brachytherapy. Surgery includes radical prostatectomy.
Data source: Provincial cancer agencies.
Figure 4.22a
Percentage of high-risk prostate cancer patients receiving various types of treatment† for men aged 75 or younger, by province — 2010 diagnosis year
† This indicator looks at treatment patterns within one year of diagnosis and within one year post-surgery for adjuvant radiation therapy. ‡ The categories 'Radiation therapy only' and 'Surgery with adjuvant radiation therapy' were combined due to small numbers and/or to avoid residual disclosure.
*Supressed due to small numbers.
Radiation therapy includes both external beam radiation therapy and brachytherapy. Surgery includes radical prostatectomy.
No record of treatment may include, but is not limited to, surgeries other than radical prostatectomy, active surveillance, watchful waiting, hormone therapy, chemotherapy and patient refusal.
Data source: Provincial cancer agencies.
Data Table
Province
Type of Primary Treatment
Cases
Percent (%)
Lower bound of 95% confidence interval
Upper bound of 95% confidence interval
BC
No record of treatment
145
22.4
19.2
25.8
BC
Radiation therapy only
266
41.0
37.2
44.9
BC
Surgery with adjuvant radiation therapy
69
10.6
8.4
13.3
BC
Surgery only
168
25.9
22.6
29.5
AB
No record of treatment
84
30.4
25.1
36.2
AB
Radiation therapy only
137
49.6
43.6
55.7
AB
Surgery with adjuvant radiation therapy
19
6.9
4.2
10.5
AB
Surgery only
36
13.0
9.3
17.6
MB
No record of treatment
60
41.4
33.3
49.8
MB
Radiation therapy only/ Surgery with adjuvant radiation therapy
† This indicator looks at treatment patterns within one year of diagnosis and within one year post-surgery for adjuvant radiation therapy. ‡ The categories 'Radiation therapy only' and 'Surgery with adjuvant radiation therapy' were combined due to small numbers and/or to avoid residual disclosure.
*Supressed due to small numbers.
Radiation therapy includes both external beam radiation therapy and brachytherapy. Surgery includes radical prostatectomy.
No record of treatment may include, but is not limited to, surgeries other than radical prostatectomy, active surveillance, watchful waiting, hormone therapy, chemotherapy and patient refusal.
Data source: Provincial cancer agencies.
Figure 4.22b
Percentage of intermediate-risk prostate cancer patients receiving various types of treatment† for men aged 75 or younger, by province — 2010 diagnosis year
† This indicator looks at treatment patterns within one year of diagnosis and within one year post-surgery for adjuvant radiation therapy. ‡ The categories 'Radiation therapy only' and 'Surgery with adjuvant radiation therapy' were combined due to small numbers and/or to avoid residual disclosure.
*Supressed due to small numbers.
Radiation therapy includes both external beam radiation therapy and brachytherapy. Surgery includes radical prostatectomy. No record of treatment may include, but is not limited to, surgeries other than radical prostatectomy, active surveillance, watchful waiting, hormone therapy, chemotherapy and patient refusal.
Data source: Provincial cancer agencies.
Data Table
Province
Type of Primary Treatment
Cases
Percent (%)
Lower bound of 95% confidence interval
Upper bound of 95% confidence interval
BC
No record of treatment
99
15.8
13.1
18.9
BC
Radiation therapy only
330
52.8
48.8
56.8
BC
Surgery with adjuvant radiation therapy
21
3.4
2.1
5.1
BC
Surgery only
175
28
24.5
31.7
AB
No record of treatment
224
26.2
23.3
29.3
AB
Radiation therapy only
198
23.2
20.4
26.1
AB
Surgery with adjuvant radiation therapy
40
4.7
3.4
6.3
AB
Surgery only
393
46
42.6
49.4
MB
No record of treatment
91
38.7
32.5
45.3
MB
Radiation therapy only/ Surgery with adjuvant radiation therapy
53
22.6
17.2
28.2
MB
Surgery only
91
38.7
32.5
45.3
NS
No record of treatment
71
34.3
27.9
41.2
NS
Radiation therapy only
46
22.2
16.8
28.5
NS
Surgery with adjuvant radiation therapy
23
11.1
7.2
16.2
NS
Surgery only
67
32.4
26
39.2
PE
No record of treatment
8
22.9
10.4
40.1
PE
Radiation therapy only
*
*
*
*
PE
Radiation therapy only/ Surgery with adjuvant radiation therapy
† This indicator looks at treatment patterns within one year of diagnosis and within one year post-surgery for adjuvant radiation therapy. ‡ The categories 'Radiation therapy only' and 'Surgery with adjuvant radiation therapy' were combined due to small numbers and/or to avoid residual disclosure.
*Supressed due to small numbers.
Radiation therapy includes both external beam radiation therapy and brachytherapy. Surgery includes radical prostatectomy. No record of treatment may include, but is not limited to, surgeries other than radical prostatectomy, active surveillance, watchful waiting, hormone therapy, chemotherapy and patient refusal.
Data source: Provincial cancer agencies.
Figure 4.22c
Percentage of low-risk prostate cancer patients receiving various types of treatment† for men aged 75 or younger, by province — 2010 diagnosis year
† This indicator looks at treatment patterns within one year of diagnosis and within one year post-surgery for adjuvant radiation therapy. ‡ The categories 'Radiation therapy only' and 'Surgery with adjuvant radiation therapy' were combined due to small numbers and/or to avoid residual disclosure.
*Supressed due to small numbers.
Radiation therapy includes both external beam radiation therapy and brachytherapy. Surgery includes radical prostatectomy. No record of treatment may include, but is not limited to, surgeries other than radical prostatectomy, active surveillance, watchful waiting, hormone therapy, chemotherapy and patient refusal.
Data source: Provincial cancer agencies.
Data Table
Province
Type of Primary Treatment
Cases
Percent (%)
Lower bound of 95% confidence interval
Upper bound of 95% confidence interval
BC
No record of treatment
123
46.8
40.6
53.0
BC
Radiation therapy only
72
27.4
22.1
33.2
BC
Surgery with adjuvant radiation therapy
5
1.9
0.6
4.4
BC
Surgery only
63
24.0
18.9
29.6
AB
No record of treatment
179
39.9
35.3
44.6
AB
Radiation therapy only
97
21.6
17.9
25.7
AB
Surgery with adjuvant radiation therapy
5
1.1
0.4
2.6
AB
Surgery only
168
37.4
32.9
42.1
MB
No record of treatment
64
71.1
60.6
80.2
MB
Radiation therapy only/ Surgery with adjuvant radiation therapy
† This indicator looks at treatment patterns within one year of diagnosis and within one year post-surgery for adjuvant radiation therapy. ‡ The categories 'Radiation therapy only' and 'Surgery with adjuvant radiation therapy' were combined due to small numbers and/or to avoid residual disclosure.
*Supressed due to small numbers.
Radiation therapy includes both external beam radiation therapy and brachytherapy. Surgery includes radical prostatectomy. No record of treatment may include, but is not limited to, surgeries other than radical prostatectomy, active surveillance, watchful waiting, hormone therapy, chemotherapy and patient refusal.
Data source: Provincial cancer agencies.
Figure 4.23a
Percentage of high-risk prostate cancer patients receiving various types of treatment† for men over age 75, by province — 2010 diagnosis year
† This indicator looks at treatment patterns within one year of diagnosis and within one year post-surgery for adjuvant radiation therapy. ‡ The categories 'Radiation therapy only' and 'Surgery with adjuvant radiation therapy' were combined due to small numbers and/or to avoid residual disclosure. The categories 'Radiation therapy only' and 'Surgery only' were combined for the same reason.
*Supressed due to small numbers.
Radiation therapy includes both external beam radiation therapy and brachytherapy. Surgery includes radical prostatectomy. No record of treatment may include, but is not limited to, surgeries other than radical prostatectomy, active surveillance, watchful waiting, hormone therapy, chemotherapy and patient refusal.
Data source: Provincial cancer agencies.
Data Table
Province
Type of Primary Treatment
Cases
Percent (%)
Lower bound of 95% confidence interval
Upper bound of 95% confidence interval
BC
No record of treatment
87
39.4
32.9
46.1
BC
Radiation therapy only/ Surgery with adjuvant radiation therapy
† This indicator looks at treatment patterns within one year of diagnosis and within one year post-surgery for adjuvant radiation therapy. ‡ The categories 'Radiation therapy only' and 'Surgery with adjuvant radiation therapy' were combined due to small numbers and/or to avoid residual disclosure. The categories 'Radiation therapy only' and 'Surgery only' were combined for the same reason.
*Supressed due to small numbers.
Radiation therapy includes both external beam radiation therapy and brachytherapy. Surgery includes radical prostatectomy. No record of treatment may include, but is not limited to, surgeries other than radical prostatectomy, active surveillance, watchful waiting, hormone therapy, chemotherapy and patient refusal.
Data source: Provincial cancer agencies.
Figure 4.23b
Percentage of intermediate-risk prostate cancer patients receiving various types of treatment† for men over age 75, by province — 2010 diagnosis year
† This indicator looks at treatment patterns within one year of diagnosis and within one year post-surgery for adjuvant radiation therapy. ‡ The categories 'Radiation therapy only' and 'Surgery with adjuvant radiation therapy' were combined due to small numbers and/or to avoid residual disclosure. The categories 'Radiation therapy only' and 'Surgery only' were combined for the same reason.
*Supressed due to small numbers.
Radiation therapy includes both external beam radiation therapy and brachytherapy. Surgery includes radical prostatectomy. No record of treatment may include, but is not limited to, surgeries other than radical prostatectomy, active surveillance, watchful waiting, hormone therapy, chemotherapy and patient refusal.
Data source: Provincial cancer agencies.
† This indicator looks at treatment patterns within one year of diagnosis and within one year post-surgery for adjuvant radiation therapy. ‡ The categories 'Radiation therapy only' and 'Surgery with adjuvant radiation therapy' were combined due to small numbers and/or to avoid residual disclosure. The categories 'Radiation therapy only' and 'Surgery only' were combined for the same reason.
*Supressed due to small numbers.
Radiation therapy includes both external beam radiation therapy and brachytherapy. Surgery includes radical prostatectomy. No record of treatment may include, but is not limited to, surgeries other than radical prostatectomy, active surveillance, watchful waiting, hormone therapy, chemotherapy and patient refusal.
Data source: Provincial cancer agencies.
Figure 4.23c
Percentage of low-risk prostate cancer patients receiving various types of treatment† for men over age 75, by province — 2010 diagnosis year
† This indicator looks at treatment patterns within one year of diagnosis and within one year post-surgery for adjuvant radiation therapy. ‡ The categories 'Radiation therapy only' and 'Surgery with adjuvant radiation therapy' were combined due to small numbers and/or to avoid residual disclosure. The categories 'Radiation therapy only' and 'Surgery only' were combined for the same reason.
*Supressed due to small numbers.
Radiation therapy includes both external beam radiation therapy and brachytherapy. Surgery includes radical prostatectomy. No record of treatment may include, but is not limited to, surgeries other than radical prostatectomy, active surveillance, watchful waiting, hormone therapy, chemotherapy and patient refusal.
Data source: Provincial cancer agencies.
† This indicator looks at treatment patterns within one year of diagnosis and within one year post-surgery for adjuvant radiation therapy. ‡ The categories 'Radiation therapy only' and 'Surgery with adjuvant radiation therapy' were combined due to small numbers and/or to avoid residual disclosure. The categories 'Radiation therapy only' and 'Surgery only' were combined for the same reason.
*Supressed due to small numbers.
Radiation therapy includes both external beam radiation therapy and brachytherapy. Surgery includes radical prostatectomy. No record of treatment may include, but is not limited to, surgeries other than radical prostatectomy, active surveillance, watchful waiting, hormone therapy, chemotherapy and patient refusal.
Data source: Provincial cancer agencies.
Figure 4.24a
Percentage of high-risk prostate cancer patients (men aged ≥ 35) receiving various types of radiation therapy ,† by province — 2010 diagnosis year
† This indicator looks at treatment patterns within one year of diagnosis and within one year post-surgery for adjuvant radiation therapy. ‡ The categories 'Brachytherapy only' and 'Both EBRT and Brachytherapy' were combined due to small numbers and/or to avoid residual disclosure.
*Suppressed due to small numbers.
NS: during the time period of this analysis some patients may have travelled out of province to access this service.
Data source: Provincial cancer agencies.
† This indicator looks at treatment patterns within one year of diagnosis and within one year post-surgery for adjuvant radiation therapy. ‡ The categories 'Brachytherapy only' and 'Both EBRT and Brachytherapy' were combined due to small numbers and/or to avoid residual disclosure.
*Suppressed due to small numbers.
NS: during the time period of this analysis some patients may have travelled out of province to access this service.
Data source: Provincial cancer agencies.
Figure 4.24b
Percentage of intermediate-risk prostate cancer patients (men aged ≥ 35) receiving various types of radiation therapy ,† by province — 2010 diagnosis year
† This indicator looks at treatment patterns within one year of diagnosis and within one year post-surgery for adjuvant radiation therapy. ‡ The categories 'Brachytherapy only' and 'Both EBRT and Brachytherapy' were combined due to small numbers and/or to avoid residual disclosure.
*Suppressed due to small numbers.
NS: during the time period of this analysis some patients may have travelled out of province to access this service.
Data source: Provincial cancer agencies.
† This indicator looks at treatment patterns within one year of diagnosis and within one year post-surgery for adjuvant radiation therapy. ‡ The categories 'Brachytherapy only' and 'Both EBRT and Brachytherapy' were combined due to small numbers and/or to avoid residual disclosure.
*Suppressed due to small numbers.
NS: during the time period of this analysis some patients may have travelled out of province to access this service.
Data source: Provincial cancer agencies.
Figure 4.24c
Percentage of low-risk prostate cancer patients (men aged ≥ 35) receiving various types of radiation therapy ,† by province — 2010 diagnosis year
† This indicator looks at treatment patterns within one year of diagnosis and within one year post-surgery for adjuvant radiation therapy. ‡ The categories 'Brachytherapy only' and 'Both EBRT and Brachytherapy' were combined due to small numbers and/or to avoid residual disclosure.
*Suppressed due to small numbers.
NS: during the time period of this analysis some patients may have travelled out of province to access this service.
Data source: Provincial cancer agencies.
† This indicator looks at treatment patterns within one year of diagnosis and within one year post-surgery for adjuvant radiation therapy. ‡ The categories 'Brachytherapy only' and 'Both EBRT and Brachytherapy' were combined due to small numbers and/or to avoid residual disclosure.
*Suppressed due to small numbers.
NS: during the time period of this analysis some patients may have travelled out of province to access this service.
Data source: Provincial cancer agencies.
Treatment patterns were examined for prostate cancer patients aged 35 years and older using data collected by provincial cancer agencies.
Metastatic prostate cancer patients were excluded from the patterns of care analysis, as GUROC risk categories are only pertinent to localized disease.
Data on the risk profiles of men with prostate cancer were not captured by the provinces, so a decision was made to deduce the profiles statistically. This was done by looking at three types of prognostic data contained in various administrative datasets: site-specific factor 1 (PSA value), site-specific factor 8 (Gleason Score), and CS extension (Clinical T-Stage). The risk factors indicator uses collaborative stage data from the provincial cancer registries. This information was extracted from patient charts, providing a contemporary risk profile of prostate cancer patients in Canada. Not all cases were captured due to incomplete data for one or more of the three prognostic factors used to calculate risk. Overall, approximately 2% to 17% of cases were excluded due to incomplete data.
This indicator looks at treatment patterns within one year of diagnosis and within one year post-surgery for adjuvant radiation therapy. This time frame will more likely differentiate active surveillance from primary treatment, and will more likely capture patients receiving adjuvant radiation therapy for the first time as opposed to those undergoing salvage therapy (i.e., treatment given after the cancer has not responded to other treatments).
As per the information presented in the Diagnosis and Staging chapter of this report, British Columbia had a high percentage of cases deemed as “stage unknown.” Risk category may not be identifiable for those cases. This may affect the comparability of the patterns of care analysis by risk category.
Data were not consistently available to allow us to examine use of androgen deprivation therapy (ADT), a form of hormone therapy. Similarly, no consistent data were available about observation approaches (i.e., active surveillance, watchful waiting) or other treatment options such as chemotherapy. Only data on EBRT, brachytherapy and surgery were available for the patterns of care indicator. So it is possible that men diagnosed in 2010 who did not have a record of treatment within one year post-diagnosis might have been suitable candidates for active surveillance or watchful waiting; they might have been treated with cryotherapy or high-intensity focused ultrasound (HIFU); they might have been prescribed ADT alone; or they might have been prescribed ADT with the intent that they would receive surgery or radiation therapy after one year. It is also possible that these men chose not to undergo treatment at that time.
Prostate cancer cases receiving primary treatment
Definition: Proportion of prostate cancer cases (men aged 35 and older) that received primary treatment by type of treatment
Numerator: Of the denominator, the total number of prostate cancer cases (men aged = 35) receiving primary treatment within one year of diagnosis by type:
Surgery only (radical prostatectomy)
Radiation therapy only (External Beam Radiation Therapy and/or Brachytherapy)
Surgery with adjuvant radiation therapy (adjuvant radiation therapy within one-year post- surgery)
*No record of treatment
Denominator: Total number of prostate cancer cases newly diagnosed in 2010
Data source: Provincial cancer agencies
Measurement timeframe: 2010 diagnosis year
Stratification variables: Risk category (low, intermediate, high), age group (35= age = 75, 75+)
Provinces submitting data: BC, AB, SK, MB, NS, PE
Province-specific notes: AB: No record of treatment includes 185 cases of surgeries that were not radical prostatectomy and 271 cases on hormone treatment. SK: Cases that were diagnosed with Stage Mx were placed into the “Unable to Classify” category.
General notes:
*No record of treatment was calculated as follows: a) For the cases that were referred to a radiation oncologist: # of no record of treatment = # of prostate cancer cases that were referred to a radiation oncologist – (# of cases that had surgery only + # of cases that had radiation therapy only + # of cases that had surgery with adjuvant radiation therapy); b) For the cases that were not referred to a radiation oncologist: # of no record of treatment = # of prostate cancer cases that were not referred to a radiation oncologist – # of cases that had surgery only.
Surgery with adjuvant radiation therapy include the cases receiving surgery within one year of diagnosis and had adjuvant radiation therapy within one year post-surgery.
Radiation therapy to the primary site only.
Only provincial residents are included.
Prostate cancer cases receiving radiation therapy
Definition: Proportion of prostate cancer cases (men aged 35 and older) that received radiation therapy by type of radiation
Numerator: Of the denominator, the total number of prostate cancer cases receiving radiation therapy by type:
External Beam Radiation Therapy (EBRT) only
Brachytherapy only
Both EBRT and Brachytherapy
Denominator: Total number of prostate cancer cases newly diagnosed in 2010
Data source: Provincial cancer agencies
Measurement timeframe: 2010 diagnosis year
Stratification variables: Risk category (low, intermediate, high), age group (35 =age = 75, 75+)
Radical prostatectomy: open versus laparoscopic surgery
Percentage of prostate cancer patients receiving radical prostatectomies, by surgical approach (%), by province — 2013-2014 combined
Prostate wait times for surgery
Median and 90th percentile surgery wait times from booking date to surgery for prostate cancer, by province — 2014
Prostate wait times for radiation therapy
Median and 90th percentile radiation therapy wait times from ready-to-treat to start of radiation for prostate cancer, by province, by risk category — 2013 treatment year
